Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: ClinicalTrials.gov is a publicly accessible, Internet-based registry of clinical trials managed by the US National Library of Medicine that has the potential to address selective trial publication. Our objectives were to examine completeness of registration within ClinicalTrials.gov and to determine the extent and correlates of selective publication. METHODS AND FINDINGS: We examined reporting of registration information among a cross-section of trials that had been registered at ClinicalTrials.gov after December 31, 1999 and updated as having been completed by June 8, 2007, excluding phase I trials. We then determined publication status among a random 10% subsample by searching MEDLINE using a systematic protocol, after excluding trials completed after December 31, 2005 to allow at least 2 y for publication following completion. Among the full sample of completed trials (n = 7,515), nearly 100% reported all data elements mandated by ClinicalTrials.gov, such as intervention and sponsorship. Optional data element reporting varied, with 53% reporting trial end date, 66% reporting primary outcome, and 87% reporting trial start date. Among the 10% subsample, less than half (311 of 677, 46%) of trials were published, among which 96 (31%) provided a citation within ClinicalTrials.gov of a publication describing trial results. Trials primarily sponsored by industry (40%, 144 of 357) were less likely to be published when compared with nonindustry/nongovernment sponsored trials (56%, 110 of 198; p<0.001), but there was no significant difference when compared with government sponsored trials (47%, 57 of 122; p = 0.22). Among trials that reported an end date, 75 of 123 (61%) completed prior to 2004, 50 of 96 (52%) completed during 2004, and 62 of 149 (42%) completed during 2005 were published (p = 0.006). CONCLUSIONS: Reporting of optional data elements varied and publication rates among completed trials registered within ClinicalTrials.gov were low. Without greater attention to reporting of all data elements, the potential for ClinicalTrials.gov to address selective publication of clinical trials will be limited. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical trial registries are an important source of information for tracking clinical trials from their inception through to their reporting, and have been used to measure publication bias and outcome reporting bias.”
From Systematic review protocol assessing the processes for linking clinical trial registries and their published results (2016) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675 · cited 2×
“Similarly unpublished clinical trials of rosiglitazone [3] identified from a company-maintained website and of erythropoiesis-stimulating agents [4] and antidepressants [5] found among data submitted to the FDA revealed important efficacy and safety information to be missing from the medical literature.”
BackgroundSelf-citationSilverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109 · cited 1×
“Many studies have attempted to evaluate the extent of selective publication in the biomedical literature and found similarly low rates of publication [5,12–24], although none have used, to our knowledge, as large and as broadly representative a registry as ClinicalTrials.”
BackgroundSelective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435 · cited 3×
“Similarly unpublished clinical trials of rosiglitazone [3] identified from a company-maintained website and of erythropoiesis-stimulating agents [4] and antidepressants [5] found among data submitted to the FDA revealed important efficacy and safety information to be missing from the medical literature.”
BackgroundResultPharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“However, we also found significantly different publication rates among study types and primary sponsors, consistent with prior research [11].”
ResultChan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845 · cited 1×
“Given the documented presence of outcome reporting bias among trials studied in other settings [5,12,13], the potential impact of ClinicalTrials.”
ResultRisk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741 · cited 1×
“Other evidence concerning selective publication is anecdotal, such as the absence of 6 mo of trial data from a key publication describing the efficacy of celecoxib [25,26], the delay of publication for two early trials of rofecoxib until after the medication was withdrawn from the market [27–29], and the aforementione…”
BackgroundSystematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
Dwan, K., Altman, D. G., Arnaiz, J. A., Bloom, J., Chan, A.-W., Cronin, E., Decullier, E., Easterbrook, P. J., Von Elm, E., Gamble, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003081 · Cited by 1,546 · cited 1×
“Many studies have attempted to evaluate the extent of selective publication in the biomedical literature and found similarly low rates of publication [5,12–24], although none have used, to our knowledge, as large and as broadly representative a registry as ClinicalTrials.”
BackgroundClinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejme048225 · Cited by 1,241
Dickersin, K. (1992) · JAMA · doi:10.1001/jama.1992.03480030052036 · Cited by 854
Cited by
Items 301–400 of 400
Pavić, M., Tokalić, R., & Marušić, A. (2024) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2024.111570 · Cited by 3
Publication and associated factors of clinical trials registered in Peru
Heredia, P., Alarcon-Ruiz, C. A., Roque‐Roque, J. S., Cruz-Vargas, J. A. D. L., & Quispe, A. M. (2020) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12413 · Cited by 4
Subgroup Analysis in Pulmonary Hypertension-Specific Therapy Clinical Trials: A Systematic Review
Ramallo, H. R., Gutiérrez, N. B., Otero, R., Flores-Moreno, S., & Martín, L. A.-K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060863 · Cited by 5
Showell, M. G., Farquhar, C. M., Greenwood, G., & Jordan, V. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072446 · Cited by 5
Sawata, H., Ueshima, K., & Tsutani, K. (2011) · Trials · doi:10.1186/1745-6215-12-96 · Cited by 3
“When we examined the changes in numbers of ‘unpublished trials’ in Table 7, the number did not decline between 2004 and 2009, resembling the global situation in which 54% of the trials were unpublished [ 16 ].”
Systematic characterization of gastrointestinal clinical trials
Espinoza, M., Hsieh, A., & Hsiehchen, D. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.01.003 · Cited by 4
Traversa, G., Masiero, L., Sagliocca, L., & Trotta, F. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0420-4 · Cited by 5
“In a cross-sectional analysis concerning 10 % of trials that had been registered in CTG after December 1999 and updated as being completed by June 2007, less than half (311/677, 46 %) were published [15].”
BackgroundDigital smile enhancement: an essential modality for any successful cosmetic practice.
Ringer, J. (2007) · PubMed · Cited by 3
Gene-Based Therapies for Leber Hereditary Optic Neuropathy. Hype or Hope?
Mackey, D. A., Kearns, L. S., & Hewitt, A. W. (2016) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000220 · Cited by 3
“We need to distinguish proper clinical trials from quackery (some of which still get registered as a clinical trial) and encourage patients to participate.(21) They must ask the following: Is the trial registered as a clinical trial? What ethics/ institutional review board approval is in place and from where? How is t…”
BackgroundCharacteristics of completed clinical trials for spinal cord injury from 1999 to 2020
Onyedimma, C., Moinuddin, F. M., Yolcu, Y. U., Illies, A. J. C., Sammak, S. E., Trammell, B. C., Hunt, C., Qu, W., & Bydon, M. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.10.002 · Cited by 5
Card, J. J., & Kuhn, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.11004-9 · Cited by 3
Trial registration cannot alone transform scientific conduct
Moja, L. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2009.252 · Cited by 4
“and, finally, the 'disappearance' of many trials that are registered but never find their way to publication”
BackgroundGrant Applications With a Result-Based Orientation
Krumholz, H. M. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000562 · Cited by 3
Self-citationLei, L.-X., Li, K., Yu, W., Feng, J., Zhang, H.-L., Chen, M.-K., Dong, W.-X., Chen, J.-X., Li, J., Wang, J., et al. (2025) · American Journal of Men s Health · doi:10.1177/15579883251325478 · Cited by 2
“Consistent findings have been observed in other studies (Becker et al., 2014; Prayle et al., 2012; Ross et al., 2009, 2012; Saito & Gill, 2014).”
„Garbage in – garbage out“ – wenn die journalistischen Quellen vergiftet sind
Zimmermann, T. P. (2014) · Springer eBooks · doi:10.1007/978-3-658-02427-7_19 · Cited by 2
Fujii, H., Yukawa, K., & Satō, H. (2016) · Health · doi:10.4236/health.2016.815169 · Cited by 2
Reporting and Interpreting of Results
Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015) · Springer eBooks · doi:10.1007/978-3-319-18539-2_20 · Cited by 2
Al-Durra, M., Nolan, R. P., Seto, E., & Cafazzo, J. A. (2022) · Digital Health · doi:10.1177/20552076221090034 · Cited by 2
In Silico Drug Repositioning for COVID-19: Progress and Challenges
Kumar, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_24 · Cited by 2
Linking Cancer Clinical Trials to their Result Publications.
Pan, E., & Roberts, K. E. (2024) · PubMed Central · Cited by 3
Hughes, E. A. G., Bakel, T. V., Raudanskis, A., Ray, P., Hodzic-Santor, B. H., Purohit, U., Sacks, C. A., & Fralick, M. (2024) · The Journal of Law Medicine & Ethics · doi:10.1017/jme.2024.135 · Cited by 2
“18 Consider the previously cited example of Paxil by GlaxoSmithKline, which was prescribed to adolescents for years before it was confirmed not only to be ineffective, but to cause serious side effects including self-injury and suicide.”
Zaveri, A. J., Pietrobon, R. S., Ermilov, T., Martin, M., Heino, N., & Auer, S. (2010) · Research Publications (Maastricht University) · Cited by 2
Avances y retos en el registro de ensayos clínicos en américa Latina y el Caribe
Revéiz, L., Saénz, C., Murasaki, R. T., Cuervo, L. G., & Ramalho, L. (2014) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2011.284.434 · Cited by 5
Reporting of Negative Randomized Trials in Three Major Medical Journals
Brooks, G. A., Bowles, D. W., Jamieson, D. B., Huang, J. V., Smart, A., Heist, K., Yamashita, T. E., Prochazka, A. V., & Gopal, R. K. (2013) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2013.42021 · Cited by 2
“Do these findings cast doubt on the utility of clinical trial registration as a tool to increase the transparency of clinical research? It seems probable that standards of adequacy for trial registration have not been sufficient [12,13], and stricter enforcement of registration standards as well as new laws requiring…”
BackgroundSearching Medical Literature Effectively
Kim, H. J., & Ahn, H. S. (2015) · Hanyang Medical Reviews · doi:10.7599/hmr.2015.35.1.18 · Cited by 2
“Gov에 연구가 등록되고 진행되었으나, 이들 연구 중 연구결과가 보고되거나 출판되는 경우는 제한적이며, 한 연구 에서는 46%만이 출판되었음을 제시하고 있다[11].”
Withycombe, B. M., Ovenell, M., Meeker, A. S., Ahmed, S. M., & Hartung, D. M. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.04.007 · Cited by 2
Translational Science on Trialome: Retrolective Study of Publishing Results of Clinical Trials.
Huser, V., & Cimino, J. J. (2012) · AMIA · Cited by 2
Research integrity and the law that never was
Mayer, M. G. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-110993 · Cited by 2
Delayed publication of clinical trials in gynecologic oncology
Salinaro, J. R., Rossi, E. C., Penvose, K. N., Zhang, Y., & Darling, A. J. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.03.018 · Cited by 2
Through the looking glass: evaluating the dissemination of research in cardiology
Ross, J. S., & Nallamothu, B. K. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs160 · Cited by 2
Self-citationCustomisable query resolution in biology and medicine
Ansell, P., Hogan, J. M., & Roe, P. (2010) · Cited by 2
Fractional Exhaled Nitric Oxide
Manaker, S. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.12.007 · Cited by 2
“1124 Editorial or Medicare are often not completed or published in a timely manner.(10,11) Postmarketing studies can be critically important, and lead to product recall [eg, drotrecogin alfa (Xigris)] or recognition that seemingly therapeutic innovations are truly beneficial only for highly selected subpopulations (eg…”
BackgroundReporting and Interpreting of Results
Friedman, L. M., Furberg, C. D., & DeMets, D. L. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1586-3_19 · Cited by 2
Quality of biopharmaceuticals: Comparability exercise and post-approval surveillance
Alsamil, A. M. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1484 · Cited by 2
Research waste in total knee arthroplasty studies: an observational study on registered trials
Iken, A. R., Schaap, M., Poolman, R. W., & Gademan, M. G. J. (2026) · BMJ Open · doi:10.1136/bmjopen-2024-092409 · Cited by 2
Taherifard, E., Mooghali, M., Hakimian, H. R. L., Mane, S. R., Fu, M., Bamford, S., Berlin, J. A., Childers, K., Desai, N. R., Gross, C. P., et al. (2026) · BMJ · doi:10.1136/bmj-2026-100460 · Cited by 1
Self-citationWieseler, B. (2010) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2010.03.031 · Cited by 1
Ross, S., Magee, L. A., & Wood, S. L. (2011) · Trials · doi:10.1186/1745-6215-12-s1-a52 · Cited by 1
Implications of clinical trial data sharing for medical writers
Ross, J. S., & Krumholz, H. M. (2013) · Medical Writing · doi:10.1179/2047480612z.00000000085 · Cited by 1
“Today, physicians and other clinicians often recommend treatment options to patients on the basis of information that is incomplete: not all clinical trials are published and made available and not all outcomes collected during a clinical trial are reported and made available, even when the trial is published.(9,11,12…”
BackgroundSelf-citationWerner, M. U. (2013) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2013.04.003 · Cited by 1
Intérêts et conflits d’intérêts: le point de vue d’un expert
Martin, A. (2010) · ONCOLOGIE · doi:10.1007/s10269-010-1956-x · Cited by 1
“Un travail [46] montre qu’il n’y pas de différence”
Pediatric Clinical Trial Activity for Antipsychotics and the Sharing of Results
Glanaghy, E. M., Pietro, N. C. D., & Wilfond, B. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800016-8.00005-2 · Cited by 1
Publication of Lung Cancer Clinical Trials in Japan
Ochi, N., Honda, Y., Yamane, H., Umemura, S., Hotta, K., Tanimoto, M., Kiura, K., & Takigawa, N. (2015) · Haigan · doi:10.2482/haigan.55.1070 · Cited by 1
Clinical trials in rhinosinusitis: Identifying areas for improvement
Ramsey, T., Lai, W., Guo, E. W., Svider, P. F., Zuliani, G. F., Eloy, J. A., & Folbe, A. J. (2017) · The Laryngoscope · doi:10.1002/lary.26912 · Cited by 1
“This journal publication rate is similar to the rates from previous analyses on clinical trials outcomes.(13,14) There are several possible reasons for why the remaining 48.”
ResultVier Schritte zu mehr Transparenz in der klinischen Forschung
Kleist, P. (2013) · Bulletin des Médecins Suisses · doi:10.4414/saez.2013.01354 · Cited by 1
Mishra, B., Agarwal, A., Nilima, N., Srivastava, M. V. P., & Vishnu, V. Y. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13669 · Cited by 1
Furlan, J. C., Furlan, D. T., & Márquez-Chin, C. (2022) · PubMed · doi:10.1097/phm.0000000000001811
Menon, V., Varadharajan, N., Joseph, R., Praharaj, S. K., & Andrade, C. (2023) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_366_22 · Cited by 3
“[8] We chose to include both clinical trials and observational studies because the concerns (expressed in previous paragraphs) related to clinical trials apply to observational studies, as well.”
Factors affecting the non-publication of clinical trials of prevalent urological cancer
Alhajahjeh, A. A., Hmeidan, M., Abdulelah, A., Al-Nezaa, I., Al-Abbadi, F., Dobbs, R. W., Sater, Z. A., Awamlh, B. A. H. A., Lee, D. I., & Shahait, M. (2024) · World Journal of Urology · doi:10.1007/s00345-024-05135-6 · Cited by 1
“Thus, while some studies result in negative or equivocal results contrary to the investigators’ hypoth - esis, it remains imperative to disseminate results to research further and, ultimately, improve patient care [6].”
Jakubowski, S., Kawalec, P., & Malinowski, K. P. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1558987 · Cited by 1
Intérêts et conflits d’intérêts en nutrition
Martin, A. (2010) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2010.01.001 · Cited by 1
Moving Forward From rhBMP-2: Open Science and Data Sharing
Low, J. B., Ross, J. S., & Krumholz, H. M. (2014) · Spine · doi:10.1097/brs.0000000000000256 · Cited by 1
Self-citationEfficacy and Safety of Duloxetine in Patients With Chronic Low Back Pain
Deyo, R. A. (2010) · Spine · doi:10.1097/brs.0b013e3181d3cf15 · Cited by 2
Linking Trials to Publications: Enhancing Recall by Identifying Trial Registry Mentions in Full-TextPreprint
Holt, A. W., & Smalheiser, N. R. (2025) · medRxiv · doi:10.1101/2025.06.09.25329285 · Cited by 1
Trial Reports: Improving Reporting, Minimizing Bias, and Producing Better Evidence‐Based Practice
Shamseer, L., Turner, L., & Moher, D. (2014) · Wiley eBooks · doi:10.1002/9781118596333.ch54
Responsible Parties—Is It Time to Clean Up Your ACTs?
Vakarcs, F. (2014) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479014529115
“Prior literature indicates that poorly maintained ACT records have been an ongoing problem.(9,10) Yet, prior statistics TERM DEFINITIONS”
ResultRejected results: Addressing transparency in clinical trials
Fitzgerald, J., Chapman, S., Harrison, E. M., & Bhangu, A. A. (2015) · Bulletin of The Royal College of Surgeons of England · doi:10.1308/147363515x14272809070889
Reade, M. C., & Kirkman, E. (2013) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-642-35109-9_14
“The system is not perfect: Of registered trials completed before 2007, only 46 % had been published at the time of a 2009 systematic review [43].”
BackgroundArmAcI: le nuove norme emA drug data access: the new emA policy
Banzi, R., Bertelè, V., & Garattini, S. K. (2014)
Outcome Reporting in Surgical Randomized Controlled Trials
Glen, P. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5642
On trees and forests. Meta-analysis and between-study heterogeneity in practice
Hout, J. I. (2016) · Radboud Repository (Radboud University)
Murakami, T., Ishihara, K., Matsumoto, K., Okamura, K., Yaguchi, Y., Ono, C., Fujii, H., & Hashiba, N. (2015) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.68.73 · Cited by 4
Editorial: Do mechanistic studies have more to prove than positive results?
Edwards, S. (2012) · Research Ethics · doi:10.1177/1747016112464753
“However, the problem is seemingly not solved, as it is accessible only to public authorities (unlike in the US where ClinicalTrials.gov is publicly accessible) and is not complete (Ross et al., 2009).”
BackgroundThe value of publishing negative studies: Introducing IJS Short Reports
Agha, R. (2016) · IJS Short Reports · doi:10.4103/2468-7332.186170
“showed that only 42% of trials that stated they concluded in 2005 were actually published over two years later.[4] They concluded by stating that “The scientific community should be prioritizing the timely and accurate publication and dissemination of clinical trial results, regardless of the strength and direction of…”
BackgroundCartographie globale des essais cliniques
Atal, I. (2017) · theses.fr (ABES) · doi:10.70675/79e99798z1a9ez4de0z9bb7ze0eed3cbf3a8 · Cited by 1
Transparency and Data Sharing in Clinical Research and Big Pharma
Miller, J. E. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108658867.028
Duco, L., Legendre, C., Châtellier, G., & Saint‐Jean, O. (2019) · Trends in Geriatric Healthcare · doi:10.36959/452/576
“The published trials [54] related to donepezil [15], memantine [13], rivastigmine [10], and galantamine [10], and to combinations [6].”
BackgroundPublication and Registration Bias in Randomized Clinical Trials
Al-Durra, M. (2019) · TSpace (University of Toronto) · Cited by 1
The importance of registry for systematic review and clinical trial
Soetikno, V. (2021) · Medical Journal of Indonesia · doi:10.13181/mji.ed.215620
Lei, M., Li, J., Lv, H., Lin, F., & Zhang, L. (2021) · Research Square · doi:10.21203/rs.3.rs-763055/v1
Outcomes of Clinical Trials on Osteonecrosis of the Jaw
Wu, B. W., Lee, K. C., Halepas, S., & Karlis, V. (2021) · Cureus · doi:10.7759/cureus.17984
The impact of research waste on the scientific validity and integrity of clinical trials
Wasylewski, M. T. (2019) · Edukacja · doi:10.24131/3724.190401 · Cited by 1
Challenges and Hopes: Clinical Research Towards An International Framework of TransparencyPreprint
dos Santos, D. H. M. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3900706
Gray Matter Analysis of MRI Images: Introduction to Current Research Practice
Hamada, H. T., Matsuyoshi, D., & Kanai, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00163-8
Information Technology's Role in Global Healthcare Systems
Wiesner, M., & Schreiweis, B. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-4679-7
Nanoinformatics approaches for information extraction and text mining in nanomedical research texts
Jimenez, D. D. L. I. (2014) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.33480
Schmaling, K. B., & Kaplan, R. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009391733.006
Schmaling, K. B., & Kaplan, R. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009391733.010
Publication Rates and Patterns of Registered Glaucoma Trials
Meller, L. L. T., Kashaf, M. S., Sambo, A. B., Cizmic, J. M., Chen, J. W., Moghimi, S., & Weinreb, R. N. (2025) · Ophthalmology · doi:10.1016/j.ophtha.2025.04.007 · Cited by 1
Hohlfeld, A., bennie, L., Kredo, T., & Clarke, M. J. (2026) · Trials · doi:10.1186/s13063-026-09753-w
“Based on previous literature, we hypothesised that 30% of RCTs were not published and that the time to journal publication takes longer than 24 months from the primary outcome completion date, regardless of cumulative or subgroup analysis [4, 23, 25, 34, 35].”
InfluentialDigital tools and services to support research replicability and verifiability
(2018) · JISC Information Environment Repository (Jisc)
Reveiz, L. (2012) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Masennuslääkkeet kiistakapulana
Gauffin, T. (2020) · Tampere University Institutional Repository (Tampere University)
Itani, M., Livsey, T., Keefer, K., Elghzali, A., Sherry, R., Harris, T., Archer, D. B., Ford, A. I., & Vassar, M. (2026) · BMC Urology · doi:10.1186/s12894-026-02077-6
La transformation du corps humain en ressource biomédicale. Etude de droit international et européen
Aurey, X. (2015) · theses.fr (ABES) · doi:10.70675/92602c7cz6972z4ae7z815eze656663fd41e · Cited by 7
Le gaspillage évitable de la recherche dans les essais cliniques
Yordanov, Y. (2019) · theses.fr (ABES) · doi:10.70675/130e8831z862fz47f2z8000z2f04c8541788
Holt, A. W., & Smalheiser, N. R. (2026) · Trials · doi:10.1186/s13063-026-09747-8
Martinić-Cezar, I. J., Pranić, S. M., Tavra, A., & Marušić, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103981
“Persistent differences between registries and journal articles remain a recognized challenge in ensuring transparency and completeness of clinical trial reporting across medical specialties [39].”
Khraisat, O., Messer, T., Harmouch, K., Alqaseer, A., Ismail, W., Samardali, H., Alkhawaldeh, E., Hammad, A., Patel, D., Sayanlar, J., et al. (2026) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2026.101949 · Cited by 2
“Similarly, the high proportion of unpublished AF trials is consistent with broader evidence demonstrating persistent non-publication in clinical research, despite policies mandating trial registration and results reporting [4,8].”
Chimakurthy, A., Susarla, V., CHAUDHARY, J. K., & Desai, O. (2026) · BMC Neurology · doi:10.1186/s12883-026-05327-0
Sun, S., Tian, C., & Peng, J. (2026) · Academic Radiology · doi:10.1016/j.acra.2026.06.025
Timeliness of publication of randomized controlled trials in rheumatology: A systematic review
Bansal, P., Khan, N. A., Singh, H., Siddiqui, M., Schram, J., Patel, S., Karri, S., Constantakos, A., Sundararajan, N., & Saldanha, I. J. (2026) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2026.153052
TrialScout links published results to trial registrations using a large language model
Ahnström, L., Brückner, T., Aspromonti, D. A., Caquelin, L., Cummins, J. D., DeVito, N., Axfors, C., Ioannidis, J. P. A., & Nilsonne, G. (2026) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2026.112484 · Cited by 2
Lu, Y., Watson, D., Bandari, J., & Quarrier, S. O. (2026) · Urolithiasis · doi:10.1007/s00240-026-02048-4
Global landscape and temporal trends of colorectal surgical trials
AlSamhori, J. F., AlSamhori, A. R. F., AlSamhori, A. F., Odisho, T., Ali, A. A., & Shahait, A. D. (2026) · Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons · doi:10.1097/ia9.0000000000000090
Chen, C. (2026) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20263585
Sautter, C. R., Kennington, D. J., Gamadia, M., Ortega, A., Parry, C., & Kotecki, K. (2026) · Cureus · doi:10.7759/cureus.117850
Failure to Post Clinical Trial Results: A Serious Threat to Public TrustPreprint
Bagdi, K., & Watve, M. (2026) · Qeios · doi:10.20944/preprints202610.2185.v1
Metadata
- Authors
- Ross, J. S., Mulvey, G. K., Hines, E. M., Nissen, S. E., & Krumholz, H. M.
- Affiliations
- Health Services Research & Development (US)
- Yale New Haven Hospital (US)
- Amherst College (US)
- Cleveland Clinic (US)
- Corresponding author
- Ross, Joseph S.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-09-08
- Volume
- 6
- Issue
- 9
- Pages
- e1000144
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC2728480
- OpenAlex
- W1970223153
- Cited by
- 401
- References
- 31
- Citations by year
- 2026: 17 · 2025: 10 · 2024: 15 · 2023: 10 · 2022: 16 · 2021: 20 · 2020: 18 · 2019: 14 · 2018: 23 · 2017: 27 · 2016: 38 · 2015: 39 · 2014: 36 · 2013: 35 · 2012: 32
- FWCI
- 24.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs (K08 AG032886)
- Hartford Foundation for Public Giving
- Amgen
- Eli Lilly and Company
- Pfizer
- Sanofi
- Health Services Research and Development
- Cleveland Clinic
- Massachusetts Medical Society
- Daiichi-Sankyo
- Novo Nordisk
- National Institute on Aging (K08AG032886)
- U.S. National Library of Medicine
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Keywords
- ClinicalTrials.gov, clinical trial registration, selective publication, publication bias, registration completeness, industry funding, publication rates, clinical trial registries, primary outcome reporting
- MeSH terms
- Clinical Trials as Topic, Cross-Sectional Studies, Drug Industry, Financing, Government, Humans, National Library of Medicine (U.S.), Periodicals as Topic, Publishing, Registries, United States, Bibliometrics, Databases, Factual, Treatment Outcome, Internet, Information Dissemination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
